CHO Pharma Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	3.21	3.58	-	0.06	3.57	0.14	Upgrade
Revenue Growth (YoY)	196.67%	-	-	-98.32%	2486.96%	-53.53%	Upgrade
Cost of Revenue	1.55	1.87	-	0	0.21	0.07	Upgrade
Gross Profit	1.66	1.71	-	0.06	3.36	0.07	Upgrade
Selling, General & Admin	34.78	31.93	29.61	24.86	20.35	21.74	Upgrade
Research & Development	234.85	219.08	239.39	326.1	193.51	287.88	Upgrade
Operating Expenses	269.62	251	269	350.96	213.85	309.62	Upgrade
Operating Income	-267.96	-249.29	-269	-350.9	-210.49	-309.56	Upgrade
Interest Expense	-0.54	-0.68	-0.08	-0.3	-0.58	-0.78	Upgrade
Interest & Investment Income	37.84	37.68	16.24	7.05	5.46	8.11	Upgrade
Currency Exchange Gain (Loss)	0.29	0.07	-0.53	-0.13	0.22	0.18	Upgrade
Other Non Operating Income (Expenses)	-	-	0.01	5.88	5.46	5.29	Upgrade
EBT Excluding Unusual Items	-230.38	-212.23	-253.36	-338.39	-199.93	-296.75	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-	-	-0.09	Upgrade
Asset Writedown	-	-	-52.73	-	-6	-	Upgrade
Pretax Income	-230.38	-212.23	-306.09	-338.39	-205.93	-296.84	Upgrade
Net Income	-230.38	-212.23	-306.09	-338.39	-205.93	-296.84	Upgrade
Net Income to Common	-230.38	-212.23	-306.09	-338.39	-205.93	-296.84	Upgrade
Shares Outstanding (Basic)	214	214	191	184	184	184	Upgrade
Shares Outstanding (Diluted)	214	214	191	184	184	184	Upgrade
Shares Change (YoY)	3.72%	11.86%	4.00%	0.04%	0.12%	0.36%	Upgrade
EPS (Basic)	-1.08	-0.99	-1.60	-1.84	-1.12	-1.62	Upgrade
EPS (Diluted)	-1.08	-0.99	-1.60	-1.84	-1.12	-1.62	Upgrade
Free Cash Flow	-248.37	-222.87	-293.13	-258.9	-196.11	-267.89	Upgrade
Free Cash Flow Per Share	-1.16	-1.04	-1.53	-1.41	-1.07	-1.46	Upgrade
Gross Margin	51.84%	47.77%	-	98.33%	94.09%	48.55%	Upgrade
Operating Margin	-8347.66%	-6963.49%	-	-584833.33%	-5896.11%	-224315.94%	Upgrade
Profit Margin	-7176.79%	-5928.10%	-	-563988.33%	-5768.21%	-215100.73%	Upgrade
Free Cash Flow Margin	-7737.35%	-6225.53%	-	-431501.67%	-5493.25%	-194121.74%	Upgrade
EBITDA	-255.98	-237.71	-250.3	-324.67	-184.88	-282	Upgrade
D&A For EBITDA	11.98	11.59	18.7	26.23	25.61	27.56	Upgrade
EBIT	-267.96	-249.29	-269	-350.9	-210.49	-309.56	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.